Ukrainian Journal Health of Woman. 2024. 6(175): 16-22. doi: 10.15574/HW.2024.6(175).1622
Tsapenko T. V.¹, Manoliak I. P.^2
1Bogomolets National Medical University, Kyiv, Ukraine
²State Scientific Institution ‘Centre for Innovative Healthcare Technologies’ of the State Administration of Ukraine for Healthcare Services, Kyiv, Ukraine

For citation: Tsapenko TV, Manoliak IP. (2024). Clinical features of the state of reproductive health of patients with submucous uterine fibroids after COVID-19. Ukrainian Journal Health of Woman. 6(175): 16-22. doi: 10.15574/HW.2024.6(175).1622
Article received: Aug 24, 2024. Accepted for publication: Nov 27, 2024.

The issue of effectively achieving the desired pregnancy still remains debatable due to the increase in infertile patients with comorbid conditions.
Aim – to determine the impact of COVID-19 on the nature of hormonal changes in patients with submucosal uterine fibroids (SUF) before and after hysteroscopic myomectomy.
Materials and methods. 112 women of reproductive age were examined, who were divided into three groups: I – 57 women with SUF who had COVID-19; II – 35 patients with SUF who did not have COVID-19; III – 20 practically healthy women. Hormonal status disorders were studied by determining the serum concentration of gonadotropic and steroid hormones by enzyme-linked immunosorbent assay after surgery in dynamics. To determine the probability of the difference in values, the Student's t-test was used. Differences were considered to be significantly significant at a level of significance of p<0.05.
Results. After the surgical intervention in the scope of hysteroscopic myectomy, according to the results of the hormonal balance studies of women in the groups I and II, it was determined that the differences between the indicators remained, which indicates pathological mechanisms of hormonal imbalance independent of uterine fibroids.
Conclusions. Patients represent a complex contingent from the point of view of the implementation of reproductive function, since hormonal changes detected before surgery, in particular a decrease in steroid hormones, high concentrations of gonadotropic hormones against the background of hyperandrogenism, contribute to the development of desynchronization of the perception of neurohumoral signals by the receptor apparatus of myositis, which leads to the development of fibroids nodes with a submucosal location. Transferred COVID-19 in patients with SUF is the main risk factor for failure to restore fertility after surgery.
The study was performed in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Local Ethics Committee. Informed consent of women was obtained for the study.
No conflict of interests was declared by the authors.
Keywords: reproductive health, uterine fibroids, menstrual disorders, infertility, diagnostics, treatment, hysteroscopy, myomectomy, COVID-19.

REFERENCES

1. Barbaresso R, Qasba N, Knee A, Benabou K. (2024, Aug). Racial Disparities in Surgical Treatment of Uterine Fibroids During the COVID-19 Pandemic. J Womens Health (Larchmt). 33(8): 1085-1094. Epub 2024 Apr 17. https://doi.org/10.1089/jwh.2023.0826; PMid:38629437

2. Barra F, La Rosa VL, Vitale SG, Commodari E, Altieri M et al. (2022, Jun). Psychological status of infertile patients who had <i>in vitro</i> fertilization treatment interrupted or postponed due to COVID-19 pandemic: a cross-sectional study. J Psychosom Obstet Gynaecol. 43(2): 145-152. https://doi.org/10.1080/0167482X.2020.1853095; PMid:33252292

3. Brown E, Kroll R, Li H, Ng J, Pinsky B, Rodriguez JW et al. (2023, Nov 1). Low-Dose Elagolix for the Treatment of Heavy Menstrual Bleeding in Patients With Uterine Leiomyomas: A Randomized Controlled Trial. Obstet Gynecol. 142(5): 1068-1076. https://doi.org/10.1097/AOG.0000000000005380

4. Chandrasiri D, Munasinghe BM, Pushpakanthan EJ, Jayasinghe J, Nissankaarachchi RD. (2022, Nov 1). Vaginal prolapse of a large uterine cervical leiomyoma complicated with cervical inversion: A case report of an extremely rare entity with review of the literature. SAGE Open Med Case Rep. 10: 2050313X221135596. https://doi.org/10.1177/2050313X221135596; PMid:36337158 PMCid:PMC9630888

5. Dykstra C, Laily A, Marsh EE, Kasting ML, DeMaria AL. (2023, Feb). "I think people should be more aware:" Uterine fibroid experiences among women living in Indiana, USA. Patient Educ Couns. 107: 107584. https://doi.org/10.1016/j.pec.2022.107584; PMid:36473404 PMCid:PMC9808590

6. Erginoz E, Taskin HE, Cavus GH, Zengin AK. (2021, Dec 17). Leiomyomatosis-like lymphangioleiomyomatosis: A case report of the colonic manifestation of tuberous sclerosis. Medicine (Baltimore). 100(50): e27723. https://doi.org/10.1097/MD.0000000000027723; PMid:34918628 PMCid:PMC8677895

7. Farah S, Hijazi M, Aoun E, Boueri M, Nasr E, Chlala W et al. (2023, Aug). Effect of COVID-19 vaccinations on menstrual cycle and postmenopausal bleeding among health care workers: A cross-sectional study. Int J Gynaecol Obstet. 162(2): 532-540. https://doi.org/10.1002/ijgo.14809; PMid:37132636

8. Gupta S, Maghsoudlou P, Ajao M, Ivar Einarsson J, Perkins King L. (2021, Oct-Dec). Analysis of COVID-19 Response and Impact on Gynecologic Surgery at a Large Academic Hospital System. JSLS. 25(4): e2021.00056. https://doi.org/10.4293/JSLS.2021.00056; PMid:34803367 PMCid:PMC8580165

9. Hill FI, Tse MP, Mills SW, Sandy JR, Elsohaby I, Barrs VR. (2024, Sep). Histopathological changes in testicular lesions in cats. J Feline Med Surg. 26(9): 1098612X241264124. https://doi.org/10.1177/1098612X241264124; PMid:39286932 PMCid:PMC11418622

10. Kow CS, Ramachandram DS, Hasan SS. (2024, Jun). Pharmacists' viewpoint on the care for patients with uterine fibroids during the COVID-19 pandemic. BJOG. 131(7): 1018. https://doi.org/10.1111/1471-0528.17477; PMid:37016474

11. Laibangyang A, Law C, Gupta G, Da Dong X, Chuang L. (2021, Aug 6). Parasitic leiomyoma causing small bowel perforation: A case report. Case Rep Womens Health. 32: e00349. https://doi.org/10.1016/j.crwh.2021.e00349; PMid:34430223 PMCid:PMC8365333

12. Laily A, Nair I, Shank SE, Wettschurack C, Khamis G, Dykstra C et al. (2024, Mar 27). Enhancing Uterine Fibroid Care: Clinician Perspectives on Diagnosis, Disparities, and Strategies for Improving Health Care. Womens Health Rep (New Rochelle). 5(1): 293-304. https://doi.org/10.1089/whr.2023.0113; PMid:38558944 PMCid:PMC10979696

13. Leyland N, Leonardi M, Murji A, Singh SS, Al-Hendy A, Bradley L. (2022, Apr). A Call-to-Action for Clinicians to Implement Evidence-Based Best Practices When Caring for Women with Uterine Fibroids. Reprod Sci. 29(4): 1188-1196. https://doi.org/10.1007/s43032-022-00877-3; PMid:35178678 PMCid:PMC8853611

14. Małecka M, Błocka-Gumowska M, Ciepiela O. (2021, Dec). Extremely severe anemia-Worsening a patient's condition in the COVID-19 pandemic era. Int J Lab Hematol. 43(6): 1256-1257. https://doi.org/10.1111/ijlh.13493; PMid:33586852 PMCid:PMC8014592

15. Murota A, Yoshi S, Okuda R, Oowada S, Yamakawa T, Kazama T et al. (2021, Aug). Successful hemostasis of bleeding gastric inflammatory fibroid polyp by endoscopic treatment in a patient with severe COVID-19. Clin J Gastroenterol. 14(4): 1008-1013. https://doi.org/10.1007/s12328-021-01402-w; PMid:33840076 PMCid:PMC8038534

16. Odejinmi F, Mallick R, Aref-Adib M, Magama Z, Strong SM. (2023, Jul). The real impact of the COVID pandemic for women with fibroids. BJOG. 130(8): 993-994. https://doi.org/10.1111/1471-0528.17475; PMid:37005908

17. Pollack B, von Saltza E, McCorkell L, Santos L, Hultman A et al. (2023, Apr 28). Female reproductive health impacts of Long COVID and associated illnesses including ME/CFS, POTS, and connective tissue disorders: a literature review. Front Rehabil Sci. 4: 1122673. https://doi.org/10.3389/fresc.2023.1122673; PMid:37234076 PMCid:PMC10208411

18. Racilan AM, Assis WA, Casalechi M, Spagnolo-Souza A, Pascoal-Xavier MA, Simões-E-Silva AC et al. (2021, Mar). Angiotensin-converting enzyme 2, the SARS-CoV-2 cellular receptor, is widely expressed in human myometrium and uterine leiomyoma. J Endometr Pelvic Pain Disord. 13(1): 20-24. https://doi.org/10.1177/2284026520954068; PMid:34307238 PMCid:PMC8287083

19. Rozenberg S, Revercez P, Fastrez M, Vandromme J, Bucella D. (2020, Sep). Suspension of ulipristal acetate for uterine fibroids during ongoing EMA's review of liver injury risk: Unfortunate timing during the Covid-19 pandemic! Eur J Obstet Gynecol Reprod Biol. 252: 300-302. https://doi.org/10.1016/j.ejogrb.2020.06.064; PMid:32650189 PMCid:PMC7320679

20. Schaas CM, Lozneanu L, Titianu M, Schaas S, Schaas B, Bujor IE et al. (2022, Nov 29). Intravascular leiomyoma‑A rare case in the context of Covid‑19 outbreak: A case report. Exp Ther Med. 25(1): 38. https://doi.org/10.3892/etm.2022.11737; PMid:36569434 PMCid:PMC9764289

21. Schmidt EO, Katz A, Stein RA. (2022, Sep-Oct). Mifepristone: A Safe Method of Medical Abortion and Self-Managed Medical Abortion in the Post-Roe Era. Am J Ther. 29(5): e534-e543. https://doi.org/10.1097/MJT.0000000000001559; PMid:35994387

22. Wang S, Farland LV, Gaskins AJ, Mortazavi J, Wang YX, Tamimi RM et al. (2023, Jun). Association of laparoscopically-confirmed endometriosis with long COVID-19: a prospective cohort study. Am J Obstet Gynecol. 228(6): 714.e1-714.e13. https://doi.org/10.1016/j.ajog.2023.03.030; PMid:36972892 PMCid:PMC10101545

23. Whitaker LHR, Middleton LJ, Priest L, Odedra S, Cheed V, Nicholls EP et al. (2023, Oct). Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding: the UCON randomised controlled trial and mechanism of action study. Southampton (UK): National Institute for Health and Care Research. https://doi.org/10.1016/j.eclinm.2023.101995; PMid:37251622 PMCid:PMC10209678

24. Zbiri S, Fauconnier A, Milcent C. (2023, Feb). Care for uterine fibroids: another casualty of the COVID pandemic. BJOG. 130(3): 321-322. https://doi.org/10.1111/1471-0528.17293; PMid:36151919

25. Zbiri S, Fauconnier A, Milcent C. (2023, Jul). Delayed treatment for uterine fibroids during the COVID-19 pandemic. BJOG. 130(8): 995-996. https://doi.org/10.1111/1471-0528.17466; PMid:37016483